Figure 3:
Influence of morphologic subtype on survival in mBT shunt classical Norwood patient cohort. K–M survival curves illustrated. (A) As with the Sano cohort, patients with atypical variant morphologies showed a trend towards poorer 30-day and 1-year survival, though not statistically significant. (B) When comparing all morphologic classes, patients with AA-MS morphology exhibited a trend towards worse survival at 30 days, similar to those patients with atypical morphologies. Beyond 100 days, however, only the atypical morphology patients showed a persistent trend towards poorer outcome as the survival curves for the typical morphologies converged.

Influence of morphologic subtype on survival in mBT shunt classical Norwood patient cohort. K–M survival curves illustrated. (A) As with the Sano cohort, patients with atypical variant morphologies showed a trend towards poorer 30-day and 1-year survival, though not statistically significant. (B) When comparing all morphologic classes, patients with AA-MS morphology exhibited a trend towards worse survival at 30 days, similar to those patients with atypical morphologies. Beyond 100 days, however, only the atypical morphology patients showed a persistent trend towards poorer outcome as the survival curves for the typical morphologies converged.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close